Cite
ZNF76 predicts prognosis and response to platinum chemotherapy in human ovarian cancer.
MLA
Tian Hua, et al. “ZNF76 Predicts Prognosis and Response to Platinum Chemotherapy in Human Ovarian Cancer.” Bioscience Reports, vol. 41, no. 12, Dec. 2021, pp. 1–15. EBSCOhost, https://doi.org/10.1042/BSR20212026.
APA
Tian Hua, Rui-min Wang, Xiao-chong Zhang, Bei-bei Zhao, Shao-bei Fan, Deng-xiang Liu, & Wei Wang. (2021). ZNF76 predicts prognosis and response to platinum chemotherapy in human ovarian cancer. Bioscience Reports, 41(12), 1–15. https://doi.org/10.1042/BSR20212026
Chicago
Tian Hua, Rui-min Wang, Xiao-chong Zhang, Bei-bei Zhao, Shao-bei Fan, Deng-xiang Liu, and Wei Wang. 2021. “ZNF76 Predicts Prognosis and Response to Platinum Chemotherapy in Human Ovarian Cancer.” Bioscience Reports 41 (12): 1–15. doi:10.1042/BSR20212026.